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Aim To estimate the burden of colorectal cancer (CRC) in 
South East Asia.
Methods We reviewed the evidence from the published 
literature found through a systematic review in Medline, 
Embase, and Global Health and from unpublished data 
on cancer registries, which were sourced from the Inter-
national Agency for Research on Cancer. Incidence rates 
were summarized by calculating descriptive statistics and 
meta-analysis estimates.
Results The crude mean incidence of CRC in South East 
Asia for both sexes was 6.95/100 000 population and the 
incidence increased with age. The crude meta-analysis es-
timate was 6.12/100 000 population (95% confidence in-
terval 5.64-6.60/100 000) and the number of new CRC cas-
es for 2000 was 32 058 (29 544-34 573).
Conclusion The rates of CRC in South East Asia were much 
lower than those reported for high-income countries, but 
higher than those reported for Sub Saharan Africa.
Received: November 15, 2013
Accepted: December 15, 2013
Correspondence to:  
Evropi Theodoratou 
Centre for Population Health 
Sciences 
College of Medicine and Veterinary 
Medicine, University of Edinburgh 
Edinburgh, UK 
E.Theodoratou@ed.ac.uk
Inka Kokki1, Angeliki 
Papana2, Harry Campbell1, 
Evropi Theodoratou1
1Centre for Population Health 
Sciences, University of Edinburgh, 
Edinburgh, UK
2Department of Economics, 
University of Macedonia, 
Thessaloniki, Greece
*The first two authors contributed 
equally.
Estimating the incidence of 
colorectal cancer in South East 
Asia
DISEASES IN LOW AND MIDDLE INCOME COUNTRIES 
 
Croat Med J. 2013;54:532-40 
doi: 10.3325/cmj.2013.54.532
533Kokki et al: Estimating the incidence of colorectal cancer in South East Asia
www.cmj.hr
The International Agency for Research on Cancer (IARC) es-
timated that approximately 1.2 million new cases of col-
orectal cancer (CRC) were diagnosed in 2008 (9.8% of all 
new cancer cases) making CRC the fourth most common 
cancer worldwide (1). In addition, CRC accounted for over 
600 000 of the 7.6 million cancer deaths. Large variations in 
incidence rates were observed, with the lowest incidence 
rates reported in regions of central Africa and south-central 
Asia and the highest in western regions of Europe, North 
America and Australia/New Zealand (1).
Although CRC is mainly a disease of the high-income 
countries, there has been a rapid increase in rates of low 
and middle income countries that have recently made the 
transition from a relatively low- or middle-income econ-
omy, such as Japan, Singapore, and eastern European 
countries (2). This is also reflected by the fact that the per-
centage of the new CRC cases recorded in the more devel-
oped regions dropped from 65% in 2002 to 59% in 2008 
(1). These changes are partly due to the aging population 
of low and middle income countries but also due to the 
link of CRC with several dietary factors and lifestyle hab-
its. In particular, several components of the diet have been 
linked with increased (red and processed meat intake) or 
decreased (dietary fiber, fruit and vegetables, vitamin D) 
CRC risk (3-7). In addition, lifestyle habits like high energy 
intake, increased body weight, low physical activity, smok-
ing and high alcohol intake have been found to be associ-
ated with increased CRC risk (7).
In high income countries, the main source of cancer data 
are cancer registries. Generally, cancer registries collect, 
maintain, and manage cancer data and they are unique 
in being able to monitor changes in cancer incidence and 
survival over long periods of time (8). However, they cov-
er less than 25% of the world’s population and it is esti-
mated that this proportion would reduce to 11% if only 
data of good quality were included (9). Currently, both 
the World Health Organization (WHO) and the IARC col-
lect data on cancer deaths from cancer registries and pro-
duce estimates of the global and regional burden of can-
cer. In particular the IARC publishes its sets of estimates 
of global cancer incidence and mortality through the 
GLOBOCAN project, with the most recent one being from 
2008 (1).
The South East (SE) Asia region includes the following 
11 countries based on the WHO classification: Bangla-
desh, Bhutan, Democratic People’s Republic of Korea, In-
dia, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thai-
land, and Timor-Leste. The 2008 GLOBOCAN database on 
cancer registries estimated that CRC was the 4th most 
common cancer in SE. Asia, with an age-standardized 
incidence rate of 6.9/100 000 and accounting for almost 
100 000 CRC cases (6% of all cancers in SE. Asia) (1). How-
ever, the reliability of the information provided in SE. Asia 
cancer registries is open to question with only 5 of the 11 
SE. Asian countries having a formal registration system for 
cancer (Bangladesh, India, Indonesia, Myanmar, and Thai-
land) (10).
In this review, we estimated the burden of CRC in the SE. 
Asia region. We reviewed the evidence from the pub-
lished literature found through a systematic review and 
unpublished data on cancer registries and we also com-
pared the estimated CRC burden in SE. Asia with that es-
timated from a similar exercise in Sub-Saharan Africa (11). 
Finally, we aimed to explore the quality and availability of 
data of cancer registries and to make suggestions for re-
search and public health policy priorities to improve con-
trol of CRC.
METHods
The data concerning colorectal cancer in SE. Asia were 
collected from published papers through a systematic re-
view of the literature, and from unpublished cancer reg-
istry data. Data from the literature were further divided 
as registry based and hospital based in order to compare 
the results of the analysis based on the data source.
search strategy for systematic analysis and data 
extraction
The search was conducted through OvidSP, using Em-
base, Global Health, and Medline as the resources. The 
search terms for the systematic data extraction from the 
published papers are presented in Supplementary Table 
1. We included primary research articles, limited to post-
1980 that were conducted in SE. Asia region, as defined 
by WHO. The studies involved any age-group or sex and 
there was no restriction on the language of publication, 
as long as a translation into English was available for the 
full article. Studies were excluded if they did not present 
clear, numerical information on the colorectal cancer in-
cidence, prevalence, and/or mortality or did not present 
a clear case definition of colorectal cancer.
The initial search of the published articles produced 
1138 results from the three databases (Embase, 
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Global Health, and Medline), while this number was re-
duced to 734 results after cross-checking the results, re-
moving duplicates, and limiting the publishing year to 
post-1980. Consequently, the article titles were read to do 
the first exclusion from the results, leaving 59 abstracts and 
full articles to read. Abstracts not fitting the inclusion crite-
ria, mostly due to wrong location of study or population, 
were removed. After reading the full texts, there were 31 
studies left to be included. Two of these were duplicates 
of two articles, published in separate journals, so they were 
also excluded, as well as a review article, leaving 28 articles 
to be included. Six more articles were recovered based on 
the references of the 28 articles. Therefore, from the sys-
tematic search, 34 papers related to colorectal cancer in SE. 
Asia were found, with publication dates ranging from 1984 
to 2012. In this review, we only examined the incidence of 
CRC and therefore the final number of the included pub-
lished papers was further reduced to 13 (12-24) (Supple-
mentary Figure 1).
Along with the systematic review, registries in countries be-
longing to the IACR Asian region and in countries of the SE. 
Asia region were contacted in an attempt to get additional 
data. In total 26 registries from 5 countries were contacted, 
but this has proved mostly unsuccessful and we only got 
one reply. However, registries from India, Thailand, and Sri 
Lanka had accessible publications online, and therefore we 
were able to extract the required information concerning 
the incident rate of CRC, avoiding duplicate results.
data analysis
This review included 43 data points available for CRC from 
the published articles and 103 data points from the reg-
istries. This provided a total of 146 data points, 90 for the 
calculation of incidence rate of CRC, 30 for colon cancer, 
and 29 for rectal cancer. Incidence estimates were either 
extracted from the included data sets or calculated using 
the data reported. All estimates were converted to inci-
dence per 100 000 of population per year to allow for di-
rect comparison between results. To estimate the mean 
(standard deviation) and median (1rst quartile Q1-3rd 
quartile Q3) of the CRC incidence rate in SE. Asia we consid-
ered all the data points together and by publication type 
(unpublished data that have been found from registries or 
from published papers) and by data source (data from can-
cer registries or hospital based data). In addition, a meta-
analysis was conducted to estimate the pooled incident 
rate and corresponding 95% confidence interval (CI) using 
both fixed and random effect models (Mantel-Haenszel 
and DerSimonian-Laird methods, respectively).
Data sets separated in age groups were also included in 
our study. A total of 640 data points were available for the 
age-group analysis, the majority of which were extracted 
from cancer registries. The age ranges were based on the 
groups used by the data sets from the IACR. From this, the 
minimum, maximum, lower quartile, upper quartile, mean, 
median, and variance were calculated for each age group 
TAblE 1. statistics for the crude annual incident rate of colorectal cancer (per year per 100 000 population), the number of cases 
and the population size. The number of data points is denoted by N (sd – standard deviation, IR – incidence rate, CI – confidence 
interval)
Number of cases Population IR IR
Colorectal 
cancer N
mean
(sd)
Median
(Q1-Q3)
mean
(sd)
median
(Q1-Q3)
Mean
(sd)
Median
(Q1-Q3)
Meta-analysis
(95% CI)
I2
(95% CI)
All data 90 715.46
(1507.54)
297
(145-544.5)
6,350,312
(13,135,119)
1,553,538
(768,715-5,884,788)
6.95
(5.56)
5.19
(2.95-9.50)
6.12
(5.64-6.60)
99%
(99-99)
Publication 
status:
systematic 
review
23 530.35
(951.39)
183
(100-294)
1,054,915
(18,519,735)
4,130,000
(828,161-7,000,000)
6.02
(8.88)
2.96
(1.87-4.56)
3.46
(2.58-4.34)
99%
(99-99)
cancer 
registries
67 779
(1657.38)
336
(192-614)
4,910,373
(10,492,508)
1,463,495
(753,241-4,452,434)
7.28
(3.87)
7.51
(3.86-10.52)
7.03
(6.43-7.63)
98%
(98-99)
P* 0.517 0.001
data  source:
hospital 
based
14 165.50
(152.45)
129.50
(72-214)
2,410,214
(2,295,942)
1,560,000
(596,734-4,572,876)
7.71
(11.14)
2.94
(1.62-8.58)
3.14
(2.21-4.07)
97%
(96-98)
cancer 
registries
76 816.76
(1620.50)
335
(185.25-616.25)
7,076,119
(14,155,981)
1,540,141
(776,199-6,245,066)
6.82
(3.88)
6.00
(3.35-9.57)
6.50
(6.00-7.00)
99%
(99-99)
P* 0.772 0.032
*P-values were calculated using t test for mean values and Mann-Whitney test for median values.
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and box-plots are presented to summarize the informa-
tion from these data. Analyses were conducted using STA-
TA 12.0 (Statacorp, College Station, TX, USA) and SPSS 21.0 
(SPSS Inc., Chicago, IL; USA) statistical software.
REsUlTs
The data sets both from the published literature and from 
the cancer registries came from five countries of the SE. 
Asia – Bangladesh, India, Nepal, Sri Lanka, and Thailand 
(Figure 1). We report the results for colorectal cancer and 
in the supplementary document we present the results 
separately for colon and rectal cancer. The majority of the 
data were from India and Thailand, ie, 35.6% of the data 
came from India, 55.6% from Thailand, 4.4% from Sri Lanka, 
3.3% from Nepal, and 1.1% from Bangladesh. Furthermore, 
74.4% of the data was extracted from cancer registries (un-
published), while the remaining was from published pa-
pers. Furthermore data from published papers were either 
from registries (19/43 = 44.2%) or hospitals (24/43 = 55.8%). 
Data sets from Nepal and Bangladesh came solely from the 
published papers.
Clusters of data sets came from larger cities (eg, New Delhi, 
Mumbai, and Kolkata) and all data sets reported CRC from 
all age groups. The data sets covered the period 1980-
2011, with the majority of studies referring to the period 
2001-2003 (21.1%), 2004-2006 (20%), 1998-2000 (11.1%), 
1997-1998 (6.7%), 1995-1997 (6.7%), and 1990-1996 (6.7%). 
(Supplementary Figure 2).
Incidence of CRC in sE. Asia
All data sets included information about the years of the 
study, the number of cases considered, and the population 
size. The years of study varied from 1 to 10, with the ma-
FIgURE 1. geographical distribution of the included data sets.
FIgURE 2. boxplot of incidence rate of colorectal cancer per 
year per 100 000 population regarding the publication type 
(published or unpublished) and the data source (cancer regis-
tries or hospitals).
FIgURE 3. Meta-analysis of the incidence rate per year per 
100 000 population of colorectal cancer
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jority of studies considering 3 years (60%), 1 year (16.7%), 
and 2 years of study (7.8%). The number of cases consid-
ered varied from 3 to 12 486 cases (the mean number of 
cases was 715), and the population varied from 14 550 to 
59 594 155 (the mean population was 6 350 312)(Supple-
mentary Figure 3 and Supplementary Figure 4).
The incidence rate per year per 100 000 population ranged 
from 0.285 to 37.43, while the majority of the incidence rates 
were below 10 (Supplementary Figure 5). The mean (SD), 
median (Q1-Q3) and meta-analysis estimate (95% CI) for the 
crude annual incidence rate are presented for all data and 
separately by publication status (published data and data 
from cancer registries) and by data source (cancer registries 
and hospital derived data) (Table 1). The mean annual crude 
incidence rate for all data combined was 6.96/100 000 pop-
ulation and the meta-analysis estimate based on random 
effects model was 6.12 (95% CI 5.64-6.60) (Table 1, Figure 
2 and 3). When we compared the incidence rates by pub-
lication type, the mean incidence rates from the published 
papers (6.02/100 000 population) and the unpublished 
ones (7.28/100 000 population) did not differ significantly 
(P = 0.52, t test). Considering the data source, the mean inci-
dence rate from the registries was 6.82/100 000 population 
and from the hospital based data was 7.71/100 000 popu-
lation and they did not differ significantly (P = 0.77, t test). 
The highest incidents rates of CRC were observed in Ban-
gladesh (hospital based data), while the lowest ones were 
observed for India and Sri Lanka (data were both from reg-
istries and hospital based) (Figure 4).
Incidence of colon and rectal cancer in sE. Asia
The incidence rate per year per 100 000 population for co-
lon cancer ranged from 0.123 to 3.494 and for rectal can-
cer from 0.162 to 2.87. The mean (SD), median (Q1-Q3), and 
meta-analysis estimate (95% CI) for the crude annual in-
cidence rates of colon and rectal cancer were calculated. 
The mean annual crude incidence rate was 1.34/100 000 
population for colon cancer and 1.62/100 000 population 
for rectal cancer (Supplementary Table 2 and Supplemen-
tary Figure 5, Supplementary Figure 6, and Supplementary 
Figure 7).
Incidence of CRC in AE Asia from different age groups
A total of 640 data points divided into 16 age groups were 
considered for the age-specific incidence of CRC. The major-
ity of the data came from cancer registries (97.5%) and data 
were gathered from three countries: India (47.5%), Thailand 
(47.5%), and Sri Lanka (5%) (Supplementary Figure 8).
The data covered the period 1990-2006 and stemmed from 
1 year (7.5%), 2 years (15%), 3 years (62.5%), and 7 years 
(15%) of study. The number of cases considered at the data 
sets varied from 0 to 780 cases. The age-related distribu-
tion of incidence showed a substantial increase with age. 
There were large variations reported mainly in the older 
age groups, whereas for younger age groups, small varia-
tions were observed.
The mean, median, and standard deviation of the incident 
rate of CRC increased with the age group, as expected. The 
mean incident rate was consistently slightly larger than 
the estimated median for all age groups, indicating that 
the distribution of the incident rate had a positive skew 
(skewed to the right) (Table 2, Figure 5 and Supplementary 
Figure 9).
TAblE 2. statistics (mean, median, and standard deviation) for the incident rate per year per 100 000 population of colorectal cancer 
by age group
Age 
groups 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
Mean 0.0236 0.0294 0.0552 0.3242 0.7177 1.2783 2.0229 3.3105 5.3249 7.6067 12.9466 19.1601 25.2275 36.0185 42.4071 47.1406
Median 0.0000 0.0000 0.0000 0.1870 0.5590 1.1620 1.6555 2.8180 5.1465 6.9400 11.1655 17.1610 20.5305 30.8330 38.1790 35.8390
Standard 
deviation
0.0912 0.1114 0.1122 0.4100 0.6496 0.8015 1.1525 1.7017 2.3133 3.9273  7.0879 11.2500 13.5276 20.5065 25.5481 35.1429
FIgURE 4. Mean incidence rate of colorectal cancer per year 
per 100 000 population for each country (bangladesh, India, 
Nepal, sri lanka, and Thailand), regarding the publication type 
or the data source.
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When we examined the incident rate by the age groups 
for each country separately, it was again obvious that the 
incident rate increased with age, while data indicating 
the existence of CRC for ages below 40 came strictly from 
Thailand. The CRC patients for India come only from age-
groups over 40, while for Sri Lanka from age-groups over 
55 (Figure 6).
dIsCUssIoN
In the SE. Asian region a mean incidence rate of CRC was 
6.95 per year per 100 000 population, with age-specific 
rates ranging from a mean of 0.02 in the under 4-year-old 
group to 47.14 in the over-75-year-old group. When colon 
and rectal cancer were looked at separately, the mean inci-
dence rates were 1.34 and 1.62 per year per 100 000 popu-
lation, respectively. The rate derived from the meta-analy-
sis for all CRC in the region was 6.12 per year per 100 000. 
The meta-analysis also showed that cancer registries had 
a tendency to produce higher rates than hospital based 
studies, although this difference did not always reach sta-
tistical significance. This was also observed in a review 
estimating the CRC incidence rate in Sub-Saharan Africa 
(11). Several reasons might explain this difference. Hospital 
based studies will usually cover people who have present-
ed or referred to centers where there are cancer services as 
symptomatic, and who can access these health care facili-
ties, both physically and financially.
The majority of the included data were generated in the late 
1990s to early 2000s, with very little data available for the 
1980s and a limited number from the last decade. As a result, 
we estimated the number of CRC cases for the year 2000. 
When we applied the incidence rate from the meta-analy-
sis to the 2000 population of SE. Asia (25), this translated to 
32 058 new colorectal cancer cases for the year 2000 (95% CI 
29 544-34,573; based on the meta-analysis estimate).
The IACR publication GLOBOCAN from 2008 (1) reported an 
age-standardized incidence rate of 6.9/100 000, which sup-
ports our results. The incidence rate in SE. Asia was signifi-
cantly higher when compared to the estimates for Sub-Sa-
haran Africa (11), where the reported crude incidence rate 
was 4.04 cases per 100 000 population. When compared to 
a high income country such as the UK, the incidence rate 
in SE. Asia was many times lower, where the age standard-
ized incidence rate for CRC was 45.3 per 100 000 popula-
tion in 2000 (Cancer Research UK). This difference between 
CRC incidence in SE. Asia and high income countries might 
be due to underreporting and also due to poorer quality of 
cancer registration. However, since CRC is closely linked to 
poor diet, obesity, lack of exercise, and smoking these dif-
ferences might also be true.
The availability of the data from cancer registries was ben-
eficial to this review, but an aspect that could have further 
strengthened it would have been replies from other can-
cer registries with no freely available data. Twenty six reg-
istries were contacted via email, and only one replied, with 
many of the emails for registries on the IACR list for the re-
FIgURE 6. Incident rate per year per 100 000 population of 
colorectal cancer by age groups for each country.
FIgURE 5. Mean incident rate (per year per 100 000 popula-
tion) of colorectal cancer by age groups. Error bars indicate the 
95% confidence interval.
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gion being outdated. In addition, the registry that replied 
was not updated with the latest figures so they were un-
able to provide any new information.
One of the caveats of this systematic review is the limited 
availability of published or cancer-registry data from cer-
tain countries in SE. Asia, such as the Democratic People’s 
Republic of Korea, and the high volume of data from few 
countries such as India and Thailand. This may reflect the 
fact that these countries have cancer registries and have a 
more organized data collection, whereas some countries 
in the same region are behind on these developments. 
On the other hand, many of the cancer registries only cov-
er small regions within a country. In SE. Asia in particular, 
clusters of data sets came from larger cities like New Delhi, 
Mumbai, and Kolkata which are known to conduct high 
levels of research and where only 40% of the population 
lives. The prevalence of CRC risk factors in large cities might 
be higher and therefore the estimates may be exaggerated 
or under-representative of rural areas.
The quality of data in relation to publication bias could 
be improved in a couple of ways. First of all, more sourc-
es could be used to search for published literature, and 
the search could be widened to include more foreign-lan-
guage articles. Journals from the countries that did not 
provide much data could be searched for information, but 
this might require different access and more translations 
for these journals. In addition, further attempts to contact 
registries through other means or updated emails could 
be attempted. One of the problems with the data from 
countries lacking cancer screening or registries is that 
they only pick up a portion of the population with CRC. 
This can be improved by developing such practices in 
these countries.
The incidence rate estimates presented in our review for 
2000 and in GLOBOCAN for 2008 are very similar, despite 
the fact they had a different time frame. We believe that 
the lack of change in the CRC incidence rate between 2000 
and 2008 is mainly due to the use of the same data (ie, 
lack of more recent data), rather than because the rates 
have stayed stable throughout the last two decades. This is 
supported by the fact that incidence of cancer, other non-
communicable diseases, and risk factors in low and mid-
dle income countries is on the increase as these countries 
continue to develop and acquire new risk factors (26).
The increase in cancer incidence will put further pres-
sure on the health systems of SE. Asia that are not yet 
adjusted to diagnosing and managing patients with this 
condition (27). Already the quality of cancer control in low 
and middle income countries is not adequate, where there 
is lack of human resources, physical resources, and equip-
ment (28). For example in 12 countries in the Asia-Pacific 
region machine supply relevant to cancer treatment was 
sufficient to meet an estimated 23% of the current need 
(29) and only 43% of the SE. Asia countries had access to 
drugs for cancer therapy (28). In addition, the outcome 
of cancer services in low and middle income countries is 
poorer than in high income countries, with five-year sur-
vival rates being some times as half in developing coun-
tries (30). Therefore, it is clear that investments in health 
systems are required and this includes developing a supply 
of trained oncology professionals, treatment equipment, 
and cancer drugs for cancer prevention and control.
In summary, this systematic review has highlighted the lack 
of data on CRC, mirroring the lack of data for CRC in Sub-
Saharan Africa (11). There is a notable lack of data for the 
last decade and also a complete lack of data for a number 
of SE. Asia countries, which limits the representativeness of 
the review. Furthermore, communication between cancer 
registries was not very successful and complete use of the 
existing data was not possible. Non-communicable diseas-
es, including cancer, are increasing in low-income regions 
and therefore it is important that the burden of disease is 
accurately and regularly monitored. Therefore there is a 
great need to improve the volume and quality of informa-
tion available on cancer in SE. Asia and generally in low and 
middle income countries and there needs to be stronger 
investment in the existing cancer registries as well as de-
velopment of cancer registries in countries that are lacking 
one. Apart from measuring and monitoring the burden of 
cancer, cancer registries will become an invaluable source 
of evidence and guidance for policy setting, program im-
plementation, and improving practice. Finally, it is believed 
that a cost-effective strategy for managing CRC will be to 
implement policies that educate people about the health 
consequences of poor diet and lifestyle behaviors that are 
linked to CRC. Screening for CRC is thought to be cost-ef-
fective in high-income countries, however it might not be 
for low and middle income countries where the incidence 
rate is lower and where the implementation of a screen-
ing program will require the purchase and maintenance of 
expensive equipment, skilled specialists, and education of 
the public (31).
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